WHO Expert Committee on Leprosy
WHO Expert Committee on Leprosy is constituted by World Health Organization to study the worldwide progress of Leprosy.
Reports
- First report published as Technical Report Series No. 71 in 1954.
- Second report published as Technical Report Series No. 189 in 1960.[1]
- Third report published as Technical Report Series No. 319 in 1966.
- Fourth report published as Technical Report Series No. 459 in 1970.
- Fifth report published as Technical Report Series No. 607 in 1977.[2]
- Sixth report published as Technical Report Series No. 768 in 1988.
- Seventh report published as Technical Report Series No. 874 in 1998.[3] They concluded that a single dose of a combination of rifampicin, ofloxacin and minocycline is an acceptable and cost-effective alternative regimen for the treatment of single-lesion paucibacillary leprosy and the duration of the standard regimen for multibacillary leprosy could be shortened to 12 months.
References
- ↑ "Expert Committee on Leprosy (Open Library)". openlibrary.org. Retrieved 2015-01-01.
- ↑ "WHO Technical Report Series No. 607". whqlibdoc.who.int. Retrieved 2015-01-01.
- ↑ WHO Expert Committee on Leprosy (1998). WHO Expert Committee on Leprosy: Seventh Report. World Health Organization. ISBN 9789241208741. Retrieved 2015-01-01.